Work

Use of the CRISPR/Cas9‐based epigenetic gene activation system In Vivo: A new potential therapeutic modality

Year: 2018

Type: article

Abstract: sion oncology.

Source: Hepatology

DOI: 10.1002/hep.29860

Authors: Samar H. Ibrahim, Keith D. Robertson

Institution: Mayo Clinic

Language: English

Topic: CRISPR and Genetic Engineering

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1680911307, G2183015814

OpenAlex ID: W2794300658

FWCI: 0.157

Cites: 8

Cited by: 4

Related to: 10